← All companies
Avidity Biosciences, Inc.
RNA - CIK 0001599901
Market cap$1.93 B
Rank#2134
SEC filings547
The table below shows Avidity Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $350.16M | $243.91M | $254.20M | $370.19M | $575.75M | $471.40M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | $0.00 | $0.00 | $1.57M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.